Anti-Candida Albicans HSP91 Homolog Recombinant Antibody
-
产品编号
YR1109
-
别名
科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab |
Catalog Number | YR1109 |
Molecular Name | Efungumab |
CAS Number | 762260-74-2 |
Target | HSP91 homolog[Candida albicans] |
Antibody Isotype | scFv-heavy Kappa |
Clonity | Monoclonal |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Formulation | PBS, pH7.5 |
Shipping Condition | Shipped on ice packs. |
Background | Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues. |
Application | FCM, IP, ELISA, Neut, FuncS, IF, WB |
Remarks | This product is for research use only. |